** Engineering solutions provider Emerson Electric EMR.N slightly raised its annual profit forecast on Wednesday, banking on reduced cost exposure to tariffs and higher demand for its intelligent devices segment
BUMP IN THE ROAD
** Mizuho ("outperform", PT: $155) sees co executing well in choppy macro conditions; notes order rates and business momentum prospects continue to improve
** BofA Global Research ("buy", PO: $165) says incremental margins in FY26 to be boosted by synergies from both the National Instruments and AspenTech acquisitions
** Wolfe Research ("outperform", PT: $173) sees EMR's margin weakness as a "bump in the road" and expects no negative implications going into the next two years
** Morningstar (fair value: $111) says the growing skilled labor shortage benefits Emerson as manufacturers look to support human capital with smart robotics
(Reporting by Kanchana Chakravarty in Bengaluru)
((Kanchana.Chakravarty@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.